Evidence map›Paper›PMID 32017655›Full record

ReviewAnnual review of immunology2020

Caspases in Cell Death, Inflammation, and Pyroptosis.

Sannula Kesavardhana, R K Subbarao Malireddi, Thirumala-Devi Kanneganti

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 558 papers.

0numbers the graph read from it
0cells of the map it votes in
558citing papers in PubMed
41.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

558 citing papers in PubMed, 899 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. PANoptosis and Immune Remodeling in the Tumor Microenvironment.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. A non-classical necroptosis pathway mediated by caspases.Cell communication and signaling : CCS · 2026
    Article
  20. Article

498 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sannula KesavardhanaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA; email: Kesavardana.Sannula@StJude.org, Malireddi.Subbarao@StJude.org, Thirumala-Devi.Kanneganti@StJude.org.
R K Subbarao MalireddiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA; email: Kesavardana.Sannula@StJude.org, Malireddi.Subbarao@StJude.org, Thirumala-Devi.Kanneganti@StJude.org.
Thirumala-Devi KannegantiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA; email: Kesavardana.Sannula@StJude.org, Malireddi.Subbarao@StJude.org, Thirumala-Devi.Kanneganti@StJude.org.
St. Jude Children's Research Hospital · US

Funding

Role of NLR Inflammasomes in Autoinflammatory Diseases and Host DefenseR01AR056296 · NIAMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2008 to 2022
$5.9M
The Non-Inflammasome NLRs in Immunity and Host defenseR01AI124346 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2016 to 2026
$5.8M
Inflammatory Caspases in Innate Immunity and InflammationR37AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2017 to 2026
$4.9M
NLR signaling in colitis and colorectal tumorigenesisR01CA163507 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2020
$3.5M
Inflammatory Caspases in Innate Immunity and InflammationR01AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2016
$2.2M
NCI NIH HHS R01 CA163507NIAID NIH HHS R01 AI101935NIAID NIH HHS R01 AI124346NIAID NIH HHS R37 AI101935NIAMS NIH HHS R01 AR056296
6 · The paper itself

Abstract

Caspases are a family of conserved cysteine proteases that play key roles in programmed cell death and inflammation. In multicellular organisms, caspases are activated via macromolecular signaling complexes that bring inactive procaspases together and promote their proximity-induced autoactivation and proteolytic processing. Activation of caspases ultimately results in programmed execution of cell death, and the nature of this cell death is determined by the specific caspases involved. Pioneering new research has unraveled distinct roles and cross talk of caspases in the regulation of programmed cell death, inflammation, and innate immune responses. In-depth understanding of these mechanisms is essential to foster the development of precise therapeutic targets to treat autoinflammatory disorders, infectious diseases, and cancer. This review focuses on mechanisms governing caspase activation and programmed cell death with special emphasis on the recent progress in caspase cross talk and caspase-driven gasdermin D-induced pyroptosis.

Indexed as

Cell DeathAnimalsApoptosisBiomarkersCaspasesDisease SusceptibilityEnzyme ActivationGasderminsHumansInflammationNeoplasm ProteinsPyroptosisSignal TransductionBiomarkersCaspasesGasderminsGSDMA protein, humanNeoplasm Proteinsgasdermininflammasomeinflammatory caspaseinnate immunityPANoptosispyroptosis

Identifiers

PMID32017655
PMCPMC7190443
OpenAlexW3005318734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.